Fortress Biotech (FBIO) Upgraded at BidaskClub

Fortress Biotech (FBIO) Upgraded at BidaskClub


Several other research analysts have also recently issued reports on the company. HC Wainwright reaffirmed a "buy" rating and set a $11.00 target price on shares of Fortress Biotech in a research report on Tuesday, December 5th.



from Biotech News